B. Viollet

Molecular Biology · 2007–2016

A researcher in the Science corpus: 10 papers; trusts 5 researchers and is trusted by 8 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 184 citations into it; #5,428 of 17,773 by trust here, #2,020 by citations
• Surgery — 66 citations into it; #176 of 1,106 by trust here, #68 by citations

Whom B. Viollet trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Heather A. Hirsch
2. K. Inoki

Who trusts B. Viollet overall

1. Young Chul Kim

Papers from B. Viollet's perspective

Ordered by how strongly the researchers B. Viollet trusts endorse each paper. Same corpus, a different order for every researcher.

1. Role of AMP-activated protein kinase in mechanism of metformin action. (Journal of Clinical Investigation)
2. TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
3. Metformin and reduced risk of cancer in diabetic patients (British medical journal)
4. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. (Cell Metabolism)
5. TOR signaling in growth and metabolism. (Cell)
6. Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin (Diabetes Care)
7. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. (Cancer Research)
8. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. (Biochemical Journal)
9. The LKB1 tumor suppressor negatively regulates mTOR signaling. (Cancer Cell)
10. AMPK phosphorylation of raptor mediates a metabolic checkpoint. (Molecules and Cells)

Their papers

• AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 (2011) — 6,852 citations
• Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. (2007) — 939 citations
• Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. (2010) — 1,226 citations
• Metformin, Independent of AMPK, Inhibits mTORC1 In a Rag GTPase-Dependent Manner (2010) — 894 citations
• The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. (2015) — 604 citations
• AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol (2009) — 653 citations
• Cellular and molecular mechanisms of metformin: an overview. (2012) — 1,680 citations
• Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status (2016) — 611 citations
• AMPK is a negative regulator of the Warburg Effect and suppresses tumor growth in vivo (2012) — 905 citations
• Metformin: from mechanisms of action to therapies. (2014) — 1,386 citations